Form 4: Pacific Biosciences Director Meline Acquires 40,000 Shares

Director David W. Meline purchased 40,000 shares of Pacific Biosciences at an average price of $4.404 per share on March 6, 2024.

Summary

• On March 6, 2024, David W. Meline, a director of Pacific Biosciences of California, Inc., acquired 40,000 shares of the company's common stock.
• The purchase was made at a weighted average price of $4.404 per share, with individual prices ranging from $4.38 to $4.44.
• Following the transaction, Meline directly owns 40,000 shares of Pacific Biosciences.

Sentiment

Score: 6

Explanation: A director purchasing shares is generally a positive sign, suggesting confidence in the company's prospects. However, the size of the purchase is relatively small, limiting the impact on overall sentiment.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely watched by investors as they can provide insights into management's perspective on the company's valuation and future performance. A purchase by a director is generally viewed more favorably than a sale.

Key Dates